EX-99.1 2 crnc-ex99_1.htm EX-99.1 EX-99.1

img86656129_0.jpg 

 

Exhibit 99.1

Cerence Announces Fourth Quarter and Fiscal Year 2023 Results

Headlines

Revenue and profitability exceed the high end of the initially guided range for the full fiscal year
Five consecutive quarters of strong execution
Fourteen strategic design wins in the fiscal year including five competitive winbacks
Maintain a leadership position with Cerence penetration staying strong at 54% of global auto production
Fine-tuned LLM with Cerence vertical automotive dataset delivered to customers, advancing Destination Next software platform

BURLINGTON, Mass., November 27, 2023Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today reported its fourth quarter and fiscal year 2023 results for the year ended September 30, 2023.

 

Results Summary (1)

(in millions, except per share data)

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

GAAP revenue

 

$

80.8

 

$

58.1

 

 

$

294.5

 

 

$

327.9

 

GAAP gross margin

 

 

71.5

%

 

 

58.1

%

 

 

67.7

%

 

 

70.4

%

Non-GAAP gross margin

 

 

72.9

%

 

 

58.9

%

 

 

69.1

%

 

 

72.4

%

GAAP operating margin

 

 

4.8

%

 

 

-394.4

%

 

 

-9.2

%

 

 

-56.2

%

Non-GAAP operating margin

 

 

17.8

%

 

 

-9.8

%

 

 

10.8

%

 

 

23.5

%

GAAP net loss(2)(3)

 

$

(11.6

)

 

$

(230.1

)

 

$

(56.3

)

 

$

(310.8

)

GAAP net loss margin

 

 

-14.3

%

 

 

-395.8

%

 

 

-19.1

%

 

 

-94.8

%

Non-GAAP net income (loss)

 

$

3.8

 

 

$

(5.5

)

 

$

14.6

 

 

$

50.4

 

Adjusted EBITDA

 

$

16.6

 

 

$

(3.1

)

 

$

41.5

 

 

$

86.4

 

Adjusted EBITDA margin

 

 

20.5

%

 

 

-5.3

%

 

 

14.1

%

 

 

26.3

%

GAAP net loss per share - diluted

 

$

(0.29

)

 

$

(5.84

)

 

$

(1.40

)

 

$

(7.93

)

Non-GAAP net income (loss) per share - diluted

 

$

0.09

 

 

$

(0.14

)

 

$

0.36

 

 

$

1.24

 

 

(1)
Please refer to the “Discussion of Non-GAAP Financial Measures” and “Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures” included elsewhere in this release for more information regarding our use of non-GAAP financial measures.

 


img86656129_0.jpg 

 

(2)
During the third quarter of fiscal 2022, the company established a valuation allowance of $107.6 million against our deferred tax assets in a foreign jurisdiction, which consist of tax amortizable intellectual property and net operating loss carryforwards. This provision is a non-cash event.
(3)
During the fourth quarter of fiscal 2022, the company reported a goodwill impairment of $213.7 million. This provision is a non-cash event.

Stefan Ortmanns, Chief Executive Officer at Cerence, commented, “We finished the fiscal year strong with revenue for the quarter and fiscal year above the high end of the guidance range. Accordingly, we delivered better than expected full fiscal year results on all profitability metrics.”

Ortmanns continued, “During the year, we won more than a dozen strategic deals in our core auto business including five winbacks. In addition, we made strong progress in transportation adjacencies like two-wheelers and trucks. We are becoming a primary supplier of conversational AI technology in the two-wheeler space, having won every two-wheeler deal we’ve pitched.”

Ortmanns concluded, "Our industry is experiencing rapid change as automakers look to quickly deploy generative AI and large language models (LLMs), providing important opportunities for Cerence to serve as an innovation partner. We have demonstrated our initial product enhancements using these technologies to over a dozen customers with very favorable feedback, and we are already executing on a long-term product strategy that is expected to position Cerence as an industry leader for the foreseeable future.”

 


img86656129_0.jpg 

 

Cerence Key Performance Indicators

To help investors gain further insight into the Cerence business and its performance, management provides a set of key performance indicators that includes:

Key Performance Indicator1

 

Q4FY23

 

Percent of worldwide auto production with Cerence Technology (TTM)

 

 

54

%

Change in Adjusted Deferred Revenue2 (TTM):

 

 

15

%

Repeatable software contribution (TTM):

 

 

75

%

Change in number of Cerence connected cars shipped3 (TTM over prior year TTM)

 

 

34

%

Adjusted Total Billings (TTM over prior year TTM)4

 

 

6

%

 

(1)
Please refer to the “Key Performance Indicators” included elsewhere in this release for more information regarding the definition and our use of key performance indicators.
(2)
Change in Adjusted Deferred Revenue is a non-GAAP measure: Adjusted deferred revenue is calculated by adding deferred revenue and long-term deferred revenue on the balance sheet less the component associated with the Toyota Legacy contract.
(3)
Based on IHS Markit data, global auto production increased 8% over the same time period ended on September 30, 2023.
(4)
Adjusted Total Billings YoY (TTM): The year over year change in total billings adjusted to exclude Professional Services, Connected Professional Services, prepay and prepay assumptions.

First Quarter and Full Year Fiscal 2024 Outlook

For the fiscal quarter ending December 31, 2023, revenue is expected to be in the range of $128 million to $132 million, which includes $67.8 million of deferred revenue that is accelerated due to an early termination agreement, entered into in the first quarter of 2024, relating to the Toyota “Legacy” contract.

GAAP Net Income is expected to be in the range of $19 million to $23 million. Adjusted EBITDA is expected to be in the range of approximately $58 million to $62 million.

For the full fiscal year ending September 30, 2024, the company expects revenue to be in the range of $355 million to $375 million which includes $20 million of fixed contracts. GAAP Net Income is expected to be in the range of $20 million to $35 million. Adjusted EBITDA is expected to be in the range of approximately $94 million to $109 million.

The adjusted EBITDA guidance excludes acquisition-related costs, amortization of acquired intangible assets, stock-based compensation, restructuring and other costs.

Additional details regarding guidance will be provided during the earnings call.

Cerence Conference Call Webcast

The company will host a live conference call and webcast with slides to discuss the results today at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time. Interested investors and analysts are invited to dial into the conference call by using the following link:

 


img86656129_0.jpg 

 

Register Here

Webcast access will also be available on the Investor Information section of the company’s website at https://www.cerence.com/investors/events-and-resources.

A replay of the webcast can be accessed by visiting the company’s website 90 minutes following the conference call at https://www.cerence.com/investors/events-and-resources.

 

Forward Looking Statements

Statements in this press release regarding: Cerence’s future performance, results and financial condition; expected growth; multi-year targets; strategy; opportunities; business, industry and market trends; strategy regarding fixed contracts and its impact on financial results; backlog; revenue visibility; demand for Cerence products; innovation and new product offerings; cost efficiency initiatives; and management’s future expectations, estimates, assumptions, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “anticipates,” “expects,” “intends” or “estimates” or similar expressions) should also be considered to be forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risk, uncertainties and other factors, which may cause actual results or performance of the company to be materially different from any future results or performance expressed or implied by such forward-looking statements including but not limited to: the highly competitive and rapidly changing market in which we operate; adverse conditions in the automotive industry, the related supply chain and semiconductor shortage, or the global economy more generally; the impacts of the COVID-19 pandemic on our and our customers’ businesses; the impact of the war in Ukraine and conflict between Israel and Hamas on our and our customers’ businesses; our ability to control and successfully manage our expenses and cash position; escalating pricing pressures from our customers; the impact on our business of the transition to a lower level of fixed contracts, including the failure to achieve such a transition; our failure to win, renew or implement service contracts; the cancellation or postponement of existing contracts; the loss of business from any of our largest customers; effects of customer defaults; our inability to successfully introduce new products, applications and services; our strategies to increase cloud offerings and deploy generative AI and large language models (LLMs), the inability to recruit and retain qualified personnel; disruptions arising from transitions in management personnel; cybersecurity and data privacy incidents; fluctuating currency rates and interest rates; inflation; and the other factors discussed in our most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Further, the inclusion of Cerence’s multi-year targets in the accompanying presentation should not be regarded as predictive of actual future events, and such targets, which were based on numerous variables and assumptions that necessarily involve judgments, should not be relied upon as such or construed as financial guidance. Such targets cover multiple years, and thus, by their nature become subject to greater uncertainty with each successive year. Accordingly, there can be no assurance that any of the multi-year targets will be realized, and actual results may vary materially from those targets. We

 


img86656129_0.jpg 

 

disclaim any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.

Discussion of Non-GAAP Financial Measures

We believe that providing the non-GAAP information in addition to the GAAP presentation, allows investors to view the financial results in the way management views the operating results. We further believe that providing this information allows investors to not only better understand our financial performance, but more importantly, to evaluate the efficacy of the methodology and information used by management to evaluate and measure such performance. The non-GAAP information should not be considered superior to, or a substitute for, financial statements prepared in accordance with GAAP.

We utilize a number of different financial measures, both GAAP and non-GAAP, in analyzing and assessing the overall performance of the business, for making operating decisions and for forecasting and planning for future periods. While our management uses these non-GAAP financial measures as a tool to enhance their understanding of certain aspects of our financial performance, our management does not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial statements.


Consistent with this approach, we believe that disclosing non-GAAP financial measures to the readers of our financial statements provides such readers with useful supplemental data that, while not a substitute for GAAP financial statements, allows for greater transparency in the review of our financial and operational performance. In assessing the overall health of the business during the three and twelve months ended September 30, 2023 and 2022, our management has either included or excluded the following items in general categories, each of which is described below.

Adjusted EBITDA

Adjusted EBITDA is defined as net income attributable to Cerence Inc. before net income (loss) attributable to income tax (benefit) expense, other income (expense) items, net, depreciation and amortization expense, and excluding acquisition-related costs, amortization of acquired intangible assets, stock-based compensation, and restructuring and other costs, net or impairment charges related to fixed and intangible assets and gains or losses on the sale of long-lived assets, if any. From time to time we may exclude from Adjusted EBITDA the impact of events, gains, losses or other charges (such as significant legal settlements) that affect the period-to-period comparability of our operating performance. Other income (expense) items, net include interest expense, interest income, and other income (expense), net (as stated in our Condensed Consolidated Statement of Operations). Our management and Board of Directors use this financial measure to evaluate our operating performance. It is also a significant performance measure in our annual incentive compensation programs.

Restructuring and other costs, net.

Restructuring and other charges, net include restructuring expenses as well as other charges that are unusual in nature, are the result of unplanned events, and arise outside the ordinary course of our business such as employee severance costs, costs for consolidating duplicate facilities, third-party fees relating to the

 


img86656129_0.jpg 

 

modification of our convertible debt, release of a pre-acquisition contingency, and separation costs directly attributable to the Cerence business becoming a standalone public company.

Amortization of acquired intangible assets.

We exclude the amortization of acquired intangible assets from non-GAAP expense and income measures. These amounts are inconsistent in amount and frequency and are significantly impacted by the timing and size of acquisitions. Providing a supplemental measure which excludes these charges allows management and investors to evaluate results “as-if” the acquired intangible assets had been developed internally rather than acquired and, therefore, provides a supplemental measure of performance in which our acquired intellectual property is treated in a comparable manner to our internally developed intellectual property. Although we exclude amortization of acquired intangible assets from our non-GAAP expenses, we believe that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Future acquisitions may result in the amortization of additional intangible assets.

Non-cash expenses.

We provide non-GAAP information relative to the following non-cash expenses: (i) stock-based compensation; and (ii) non-cash interest. These items are further discussed as follows:

(i)
Stock-based compensation. Because of varying valuation methodologies, subjective assumptions and the variety of award types, we exclude stock-based compensation from our operating results. We evaluate performance both with and without these measures because compensation expense related to stock-based compensation is typically non-cash and awards granted are influenced by the Company’s stock price and other factors such as volatility that are beyond our control. The expense related to stock-based awards is generally not controllable in the short-term and can vary significantly based on the timing, size and nature of awards granted. As such, we do not include such charges in operating plans. Stock-based compensation will continue in future periods.
ii)
Non-cash interest. We exclude non-cash interest because we believe that excluding this expense provides management, as well as other users of the financial statements, with a valuable perspective on the cash-based performance and health of the business, including the current near-term projected liquidity. Non-cash interest expense will continue in future periods.

 


img86656129_0.jpg 

 

Other expenses.

We exclude certain other expenses that result from unplanned events outside the ordinary course of continuing operations, in order to measure operating performance and current and future liquidity both with and without these expenses. By providing this information, we believe management and the users of the financial statements are better able to understand the financial results of what we consider to be our organic, continuing operations. Included in these expenses are items such as other charges (credits), net, losses from extinguishment of debt, and changes in indemnification assets corresponding with the release of pre-spin liabilities for uncertain tax positions.

Adjustments to income tax provision.

Adjustments to our GAAP income tax provision to arrive at non-GAAP net income is determined based on our non-GAAP pre-tax income. Additionally, as our non-GAAP profitability is higher based on the non-GAAP adjustments, we adjust the GAAP tax provision to remove valuation allowances and related effects based on the higher level of reported non-GAAP profitability. We also exclude from our non-GAAP tax provision certain discrete tax items as they occur.

Key Performance Indicators

We believe that providing key performance indicators (“KPIs”) allows investors to gain insight into the way management views the performance of the business. We further believe that providing KPIs allows investors to better understand information used by management to evaluate and measure such performance. KPIs should not be considered superior to, or a substitute for, operating results prepared in accordance with GAAP. In assessing the performance of the business during the three months ended September 30, 2023, our management has reviewed the following KPIs, each of which is described below:

Percent of worldwide auto production with Cerence Technology: The number of Cerence enabled cars shipped as compared to IHS Markit car production data.
Change in Adjusted Deferred Revenue: The year over year change in deferred revenue excluding Toyota “Legacy” revenue. Amounts calculated on a TTM basis. Adjusted deferred revenue is calculated by adding deferred revenue and long-term deferred revenue on the balance sheet less the component associated with the Toyota Legacy contract.
Repeatable software contribution: The percentage of repeatable revenues as compared to total GAAP revenue in the quarter on a TTM basis. Repeatable revenues are defined as the sum of License and Connected Services revenues.
Change in number of Cerence connected cars shipped: The year over year change in the number of cars shipped with Cerence connected solutions. Amounts calculated on a TTM basis.
Adjusted Total Billings YoY (TTM): The year over year change in total billings adjusted to exclude Professional Services, prepay billings and prepay consumption.

 


img86656129_0.jpg 

 

See the tables at the end of this press release for non-GAAP reconciliations to the most directly comparable GAAP measures.

To learn more about Cerence, visit www.cerence.com, and follow the company on LinkedIn and Twitter.

 

About Cerence Inc.

Cerence (NASDAQ: CRNC) is the global industry leader in creating unique, moving experiences for the mobility world. As an innovation partner to the world’s leading automakers and mobility OEMs, it is helping advance the future of connected mobility through intuitive, AI-powered interaction between humans and their vehicles, connecting consumers’ digital lives to their daily journeys no matter where they are. Cerence’s track record is built on more than 20 years of knowledge and 475 million cars shipped with Cerence technology. Whether it’s connected cars, autonomous driving, e-vehicles, or two-wheelers, Cerence is mapping the road ahead. For more information, visit www.cerence.com.

 

Contact Information

Rich Yerganian

Senior Vice President of Investor Relations

Cerence Inc.

Tel: 617-987-4799

Email: richard.yerganian@cerence.com

 

 

 


img86656129_0.jpg 

 

CERENCE INC.

Consolidated Statements of Operations

(in thousands, except per share data)

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

License

 

$

43,105

 

 

$

19,000

 

 

$

145,159

 

 

$

158,610

 

Connected service

 

 

19,168

 

 

 

18,096

 

 

 

75,071

 

 

 

85,571

 

Professional service

 

 

18,491

 

 

 

21,048

 

 

 

74,245

 

 

 

83,710

 

Total revenues

 

 

80,764

 

 

 

58,144

 

 

 

294,475

 

 

 

327,891

 

Cost of revenues:

 

 

 

 

 

 

 

 

 

 

 

 

License

 

 

2,356

 

 

 

1,006

 

 

 

8,522

 

 

 

2,698

 

Connected service

 

 

4,777

 

 

 

5,956

 

 

 

22,995

 

 

 

22,722

 

Professional service

 

 

15,791

 

 

 

17,316

 

 

 

63,232

 

 

 

68,764

 

Amortization of intangible assets

 

 

104

 

 

 

105

 

 

 

414

 

 

 

2,984

 

Total cost of revenues

 

 

23,028

 

 

 

24,383

 

 

 

95,163

 

 

 

97,168

 

Gross profit

 

 

57,736

 

 

 

33,761

 

 

 

199,312

 

 

 

230,723

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

35,143

 

 

 

25,308

 

 

 

123,333

 

 

 

107,116

 

Sales and marketing

 

 

5,848

 

 

 

8,611

 

 

 

27,504

 

 

 

31,098

 

General and administrative

 

 

11,450

 

 

 

10,712

 

 

 

57,903

 

 

 

42,653

 

Amortization of intangible assets

 

 

557

 

 

 

2,365

 

 

 

5,854

 

 

 

11,516

 

Restructuring and other costs, net

 

 

842

 

 

 

2,379

 

 

 

11,917

 

 

 

8,965

 

Goodwill impairment

 

 

 

 

 

213,720

 

 

 

 

 

 

213,720

 

Total operating expenses

 

 

53,840

 

 

 

263,095

 

 

 

226,511

 

 

 

415,068

 

Income (loss) from operations

 

 

3,896

 

 

 

(229,334

)

 

 

(27,199

)

 

 

(184,345

)

Interest income

 

 

1,231

 

 

 

591

 

 

 

4,471

 

 

 

1,007

 

Interest expense

 

 

(3,132

)

 

 

(3,792

)

 

 

(14,769

)

 

 

(14,394

)

Other income (expense), net

 

 

(1,649

)

 

 

(255

)

 

 

1,108

 

 

 

(1,019

)

Income (loss) before income taxes

 

 

346

 

 

 

(232,790

)

 

 

(36,389

)

 

 

(198,751

)

Provision for (benefit from) income taxes

 

 

11,898

 

 

 

(2,663

)

 

 

19,865

 

 

 

112,075

 

Net loss

 

$

(11,552

)

 

$

(230,127

)

 

$

(56,254

)

 

$

(310,826

)

Net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

(0.29

)

 

 

(5.84

)

 

 

(1.40

)

 

 

(7.93

)

Diluted

 

 

(0.29

)

 

 

(5.84

)

 

 

(1.40

)

 

 

(7.93

)

Weighted-average common share outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

40,357

 

 

 

39,407

 

 

 

40,215

 

 

 

39,187

 

Diluted

 

 

40,357

 

 

 

39,407

 

 

 

40,215

 

 

 

39,187

 

 

 

 

 


img86656129_0.jpg 

 

CERENCE INC.

Consolidated Balance Sheets

(in thousands, except per share amounts)

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

101,154

 

 

$

94,847

 

Marketable securities

 

 

9,211

 

 

 

20,317

 

Accounts receivable, net of allowances of $4,044 and $157 at September 30, 2023 and September 30, 2022, respectively

 

 

61,270

 

 

 

45,073

 

Deferred costs

 

 

6,935

 

 

 

7,098

 

Prepaid expenses and other current assets

 

 

47,157

 

 

 

60,184

 

Total current assets

 

 

225,727

 

 

 

227,519

 

Long-term marketable securities

 

 

10,607

 

 

 

11,584

 

Property and equipment, net

 

 

34,013

 

 

 

37,707

 

Deferred costs

 

 

20,299

 

 

 

22,451

 

Operating lease right of use assets

 

 

11,961

 

 

 

14,702

 

Goodwill

 

 

900,342

 

 

 

890,802

 

Intangible assets, net

 

 

3,875

 

 

 

9,700

 

Deferred tax assets

 

 

46,601

 

 

 

51,989

 

Other assets

 

 

44,165

 

 

 

52,039

 

Total assets

 

$

1,297,590

 

 

$

1,318,493

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

16,873

 

 

$

10,372

 

Deferred revenue

 

 

77,068

 

 

 

72,662

 

Short-term operating lease liabilities

 

 

5,434

 

 

 

5,071

 

Short-term debt

 

 

-

 

 

 

10,938

 

Accrued expenses and other current liabilities

 

 

48,718

 

 

 

47,990

 

Total current liabilities

 

 

148,093

 

 

 

147,033

 

Long-term debt, net of discounts and issuance costs

 

 

275,951

 

 

 

259,436

 

Deferred revenue, net of current portion

 

 

145,531

 

 

 

165,972

 

Long-term operating lease liabilities

 

 

7,947

 

 

 

11,375

 

Other liabilities

 

 

25,193

 

 

 

21,727

 

Total liabilities

 

 

602,715

 

 

 

605,543

 

Stockholders' Equity:

 

 

 

 

 

 

Common stock, $0.01 par value, 560,000 shares authorized as of September 30, 2023; 40,423 and 39,430 shares issued and outstanding as of September 30, 2023 and September 30, 2022, respectively

 

 

404

 

 

 

394

 

Accumulated other comprehensive loss

 

 

(27,966

)

 

 

(33,737

)

Additional paid-in capital

 

 

1,056,099

 

 

 

1,029,542

 

Accumulated deficit

 

 

(333,662

)

 

 

(283,249

)

Total stockholders' equity

 

 

694,875

 

 

 

712,950

 

Total liabilities and stockholders' equity

 

$

1,297,590

 

 

$

1,318,493

 

 

 


img86656129_0.jpg 

 

CERENCE INC.

Consolidated Statements of Cash Flows

(in thousands)

 

 

Twelve Months Ended

 

 

 

September 30,

 

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(56,254

)

 

$

(310,826

)

Adjustments to reconcile net loss to net cash provided by (used in) operations:

 

 

 

 

 

 

Depreciation and amortization

 

 

16,038

 

 

 

23,939

 

Provision for (benefit from) credit loss reserve

 

 

3,626

 

 

 

(413

)

Stock-based compensation

 

 

40,766

 

 

 

28,076

 

Non-cash interest expense

 

 

2,914

 

 

 

5,281

 

Loss on debt extinguishment

 

 

1,333

 

 

 

-

 

Deferred tax benefit

 

 

7,597

 

 

 

97,287

 

Goodwill impairment

 

 

-

 

 

 

213,720

 

Unrealized foreign currency transaction (gain) losses

 

 

(3,393

)

 

 

5,730

 

Other

 

 

(3,388

)

 

 

385

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(16,964

)

 

 

(6,590

)

Prepaid expenses and other assets

 

 

28,192

 

 

 

(33,756

)

Deferred costs

 

 

3,194

 

 

 

4,654

 

Accounts payable

 

 

5,774

 

 

 

157

 

Accrued expenses and other liabilities

 

 

(408

)

 

 

(1,479

)

Deferred revenue

 

 

(21,529

)

 

 

(28,303

)

Net cash provided by (used in) operating activities

 

 

7,498

 

 

 

(2,138

)

Cash flows from investing activities:

 

 

 

 

 

 

Capital expenditures

 

 

(5,124

)

 

 

(17,446

)

Purchases of marketable securities

 

 

(18,025

)

 

 

(31,757

)

Sale and maturities of marketable securities

 

 

30,324

 

 

 

37,203

 

Payments for equity investments

 

 

-

 

 

 

(584

)

Other investing activities

 

 

(1,355

)

 

 

2,019

 

Net cash provided by (used in) investing activities

 

 

5,820

 

 

 

(10,565

)

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds from revolving credit facility

 

 

24,700

 

 

 

-

 

Payments of revolver credit facility

 

 

(24,700

)

 

 

-

 

Proceeds from long-term debt, net of discount

 

 

210,000

 

 

 

-

 

Payments for long-term debt issuance costs

 

 

(17,176

)

 

 

-

 

Principal payments of long-term debt

 

 

(198,438

)

 

 

(6,250

)

Common stock repurchases for tax withholdings for net settlement of equity awards

 

 

(4,894

)

 

 

(49,003

)

Principal payment of lease liabilities arising from a finance lease

 

 

(451

)

 

 

(415

)

Proceeds from the issuance of common stock

 

 

5,625

 

 

 

36,062

 

Net cash used in financing activities

 

 

(5,334

)

 

 

(19,606

)

Effects of exchange rate changes on cash and cash equivalents

 

 

(1,677

)

 

 

(1,272

)

Net change in cash and cash equivalents

 

 

6,307

 

 

 

(33,581

)

Cash and cash equivalents at beginning of period

 

 

94,847

 

 

 

128,428

 

Cash and cash equivalents at end of period

 

$

101,154

 

 

$

94,847

 

 

 


img86656129_0.jpg 

 

CERENCE INC.

Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures

(unaudited - in thousands)

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

GAAP revenue

 

$

80,764

 

 

$

58,144

 

 

$

294,475

 

 

$

327,891

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP gross profit

 

$

57,736

 

 

$

33,761

 

 

$

199,312

 

 

$

230,723

 

Stock-based compensation

 

 

1,004

 

 

 

382

 

 

 

3,703

 

 

 

3,766

 

Amortization of intangible assets

 

 

104

 

 

 

105

 

 

 

414

 

 

 

2,984

 

Non-GAAP gross profit

 

$

58,844

 

 

$

34,248

 

 

$

203,429

 

 

$

237,473

 

GAAP gross margin

 

 

71.5

%

 

 

58.1

%

 

 

67.7

%

 

 

70.4

%

Non-GAAP gross margin

 

 

72.9

%

 

 

58.9

%

 

 

69.1

%

 

 

72.4

%

 

 

 

 

 

 

 

 

 

 

 

 

GAAP operating income (loss)

 

$

3,896

 

 

$

(229,334

)

 

$

(27,199

)

 

$

(184,345

)

Stock-based compensation*

 

 

8,965

 

 

 

5,056

 

 

 

40,766

 

 

 

24,076

 

Amortization of intangible assets

 

 

661

 

 

 

2,470

 

 

 

6,268

 

 

 

14,500

 

Restructuring and other costs, net*

 

 

842

 

 

 

2,379

 

 

 

11,917

 

 

 

8,965

 

Goodwill impairment

 

 

-

 

 

 

213,720

 

 

 

-

 

 

 

213,720

 

Non-GAAP operating income (loss)

 

$

14,364

 

 

$

(5,709

)

 

$

31,752

 

 

$

76,916

 

GAAP operating margin

 

 

4.8

%

 

 

-394.4

%

 

 

-9.2

%

 

 

-56.2

%

Non-GAAP operating margin

 

 

17.8

%

 

 

-9.8

%

 

 

10.8

%

 

 

23.5

%

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net loss

 

$

(11,552

)

 

$

(230,127

)

 

$

(56,254

)

 

$

(310,826

)

Stock-based compensation*

 

 

8,965

 

 

 

5,056

 

 

 

40,766

 

 

 

24,076

 

Amortization of intangible assets

 

 

661

 

 

 

2,470

 

 

 

6,268

 

 

 

14,500

 

Restructuring and other costs, net*

 

 

842

 

 

 

2,379

 

 

 

11,917

 

 

 

8,965

 

Goodwill impairment

 

 

-

 

 

 

213,720

 

 

 

-

 

 

 

213,720

 

Depreciation

 

 

2,226

 

 

 

2,616

 

 

 

9,770

 

 

 

9,439

 

Total other income (expense), net

 

 

(3,550

)

 

 

(3,456

)

 

 

(9,190

)

 

 

(14,406

)

Provision for (benefit from) income taxes

 

 

11,898

 

 

 

(2,663

)

 

 

19,865

 

 

 

112,075

 

Adjusted EBITDA

 

$

16,590

 

 

$

(3,093

)

 

$

41,522

 

 

$

86,355

 

GAAP net loss margin

 

 

-14.3

%

 

 

-395.8

%

 

 

-19.1

%

 

 

-94.8

%

Adjusted EBITDA margin

 

 

20.5

%

 

 

-5.3

%

 

 

14.1

%

 

 

26.3

%

* - $4.0 million in stock-based compensation is included in Restructuring and other costs, net during Q1'22.

 

 

 

 


img86656129_0.jpg 

 

CERENCE INC.

Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)

(unaudited - in thousands, except per share data)

 

 

Three Months Ended

 

 

Twelve Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

GAAP net loss

 

$

(11,552

)

 

$

(230,127

)

 

$

(56,254

)

 

$

(310,826

)

Stock-based compensation*

 

 

8,965

 

 

 

5,056

 

 

 

40,766

 

 

 

24,076

 

Amortization of intangible assets

 

 

661

 

 

 

2,470

 

 

 

6,268

 

 

 

14,500

 

Restructuring and other costs, net*

 

 

842

 

 

 

2,379

 

 

 

11,917

 

 

 

8,965

 

Loss on debt extinguishment

 

 

-

 

 

 

-

 

 

 

1,333

 

 

 

-

 

Goodwill impairment

 

 

-

 

 

 

213,720

 

 

 

-

 

 

 

213,720

 

Non-cash interest expense

 

 

1,464

 

 

 

1,359

 

 

 

2,914

 

 

 

5,281

 

Indemnification asset release

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,302

 

Other

 

 

500

 

 

 

-

 

 

 

(344

)

 

 

-

 

Adjustments to income tax expense

 

 

2,870

 

 

 

(362

)

 

 

7,976

 

 

 

93,405

 

Non-GAAP net income (loss)

 

$

3,750

 

 

$

(5,505

)

 

$

14,576

 

 

$

50,423

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EPS:

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributed to common shareholders - basic and diluted

 

$

(11,552

)

 

$

(230,127

)

 

$

(56,254

)

 

$

(310,826

)

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributed to common shareholders

 

$

3,750

 

 

$

(5,505

)

 

$

14,576

 

 

$

50,423

 

Interest on the Notes, net of tax

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,068

 

Net income (loss) attributed to common shareholders - diluted

 

$

3,750

 

 

$

(5,505

)

 

$

14,576

 

 

$

54,491

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding - basic and diluted

 

 

40,357

 

 

 

39,407

 

 

 

40,215

 

 

 

39,187

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding- basic

 

 

40,357

 

 

 

39,407

 

 

 

40,215

 

 

 

39,187

 

Adjustment for diluted shares

 

 

1,101

 

 

 

-

 

 

 

423

 

 

 

4,912

 

Weighted-average common shares outstanding - diluted

 

 

41,458

 

 

 

39,407

 

 

 

40,638

 

 

 

44,099

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net loss per share - diluted

 

$

(0.29

)

 

$

(5.84

)

 

$

(1.40

)

 

$

(7.93

)

Non-GAAP net income (loss) per share - diluted

 

$

0.09

 

 

$

(0.14

)

 

$

0.36

 

 

$

1.24

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net cash provided by (used in) operating activities

 

$

11,258

 

 

$

(4,953

)

 

$

7,498

 

 

$

(2,138

)

Capital expenditures

 

 

(1,527

)

 

 

(3,028

)

 

 

(5,124

)

 

 

(17,446

)

Free Cash Flow

 

$

9,731

 

 

$

(7,981

)

 

$

2,374

 

 

$

(19,584

)

* - $4.0 million in stock-based compensation is included in Restructuring and other costs, net in Q1'22.

 

 

 


img86656129_0.jpg 

 

CERENCE INC.

Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)

(unaudited - in thousands)

 

Q4FY23

 

 

Q3FY23

 

 

Q2FY23

 

 

Q1FY23

 

GAAP revenues

 

$

80,764

 

 

$

61,660

 

 

$

68,393

 

 

$

83,658

 

Less: Professional services revenue

 

 

18,491

 

 

 

17,240

 

 

 

18,667

 

 

 

19,847

 

Non-GAAP Repeatable revenues

 

$

62,273

 

 

$

44,420

 

 

$

49,726

 

 

$

63,811

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP revenues TTM

 

$

294,475

 

 

 

 

 

 

 

 

 

 

Less: Professional services revenue TTM

 

 

74,245

 

 

 

 

 

 

 

 

 

 

Non-GAAP Repeatable revenues TTM

 

$

220,230

 

 

 

 

 

 

 

 

 

 

Repeatable software contribution

 

 

75

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


img86656129_0.jpg 

 

CERENCE INC.

Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)

(unaudited - in thousands)

 

 

Q1 2024

 

 

FY2024

 

 

Low

 

 

High

 

 

Low

 

 

High

 

GAAP revenue

 

$

128,000

 

 

$

132,000

 

 

$

355,000

 

 

$

375,000

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP gross profit

 

$

103,000

 

 

$

107,000

 

 

$

265,000

 

 

$

285,000

 

Stock-based compensation

 

 

700

 

 

 

700

 

 

 

3,100

 

 

 

3,100

 

Amortization of intangible assets

 

 

100

 

 

 

100

 

 

 

100

 

 

 

100

 

Non-GAAP gross profit

 

$

103,800

 

 

$

107,800

 

 

$

268,200

 

 

$

288,200

 

GAAP gross margin

 

 

80

%

 

 

81

%

 

 

75

%

 

 

76

%

Non-GAAP gross margin

 

 

81

%

 

 

82

%

 

 

76

%

 

 

77

%

 

 

 

 

 

 

 

 

 

 

 

 

GAAP operating income

 

$

46,500

 

 

$

50,500

 

 

$

43,300

 

 

$

58,300

 

Stock-based compensation

 

 

8,800

 

 

 

8,800

 

 

 

38,900

 

 

 

38,900

 

Amortization of intangible assets

 

 

700

 

 

 

700

 

 

 

2,300

 

 

 

2,300

 

Restructuring and other costs, net

 

 

200

 

 

 

200

 

 

 

2,400

 

 

 

2,400

 

Non-GAAP operating income

 

$

56,200

 

 

$

60,200

 

 

$

86,900

 

 

$

101,900

 

GAAP operating margin

 

 

36

%

 

 

38

%

 

 

12

%

 

 

16

%

Non-GAAP operating margin

 

 

44

%

 

 

46

%

 

 

24

%

 

 

27

%

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income

 

$

18,900

 

 

$

22,900

 

 

$

20,200

 

 

$

35,200

 

Stock-based compensation

 

 

8,800

 

 

 

8,800

 

 

 

38,900

 

 

 

38,900

 

Amortization of intangible assets

 

 

700

 

 

 

700

 

 

 

2,300

 

 

 

2,300

 

Restructuring and other costs, net

 

 

200

 

 

 

200

 

 

 

2,400

 

 

 

2,400

 

Depreciation

 

 

1,800

 

 

 

1,800

 

 

 

7,500

 

 

 

7,500

 

Total other income (expense), net

 

 

(1,800

)

 

 

(1,800

)

 

 

(7,100

)

 

 

(7,100

)

Provision for income taxes

 

 

25,800

 

 

 

25,800

 

 

 

16,000

 

 

 

16,000

 

Adjusted EBITDA

 

$

58,000

 

 

$

62,000

 

 

$

94,400

 

 

$

109,400

 

GAAP net income margin

 

 

15

%

 

 

17

%

 

 

6

%

 

 

9

%

Adjusted EBITDA margin

 

 

45

%

 

 

47

%

 

 

27

%

 

 

29

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


img86656129_0.jpg 

 

CERENCE INC.

Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)

(unaudited - in thousands)

 

 

Q1 2024

 

 

FY2024

 

 

Low

 

 

High

 

 

Low

 

 

High

 

GAAP net income

 

$

18,900

 

 

$

22,900

 

 

$

20,200

 

 

$

35,200

 

Stock-based compensation

 

 

8,800

 

 

 

8,800

 

 

 

38,900

 

 

 

38,900

 

Amortization of intangible assets

 

 

700

 

 

 

700

 

 

 

2,300

 

 

 

2,300

 

Restructuring and other costs, net

 

 

200

 

 

 

200

 

 

 

2,400

 

 

 

2,400

 

Non-cash interest expense

 

 

1,500

 

 

 

1,500

 

 

 

6,000

 

 

 

6,000

 

Other

 

 

-

 

 

 

-

 

 

 

(100

)

 

 

(100

)

Income tax impact of Non-GAAP adjustments

 

 

10,000

 

 

 

10,000

 

 

 

(10,200

)

 

 

(10,200

)

Non-GAAP net income

 

$

40,100

 

 

$

44,100

 

 

$

59,500

 

 

$

74,500

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EPS:

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributed to common shareholders

 

$

18,900

 

 

$

22,900

 

 

$

20,200

 

 

$

35,200

 

Interest on the Notes, net of tax

 

 

700

 

 

 

700

 

 

 

-

 

 

 

2,800

 

Net income attributed to common shareholders - diluted

 

$

19,600

 

 

$

23,600

 

 

$

20,200

 

 

$

38,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributed to common shareholders

 

$

40,100

 

 

$

44,100

 

 

$

59,500

 

 

$

74,500

 

Interest on the Notes, net of tax

 

 

1,100

 

 

 

1,100

 

 

 

4,500

 

 

 

4,500

 

Net income attributed to common shareholders - diluted

 

$

41,200

 

 

$

45,200

 

 

$

64,000

 

 

$

79,000

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding - basic and diluted

 

 

41,300

 

 

 

41,300

 

 

 

41,800

 

 

 

41,800

 

Adjustment for diluted shares

 

 

5,700

 

 

 

5,700

 

 

 

500

 

 

 

5,600

 

Weighted-average common shares outstanding - diluted

 

 

47,000

 

 

 

47,000

 

 

 

42,300

 

 

 

47,400

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding- basic and diluted

 

 

41,300

 

 

 

41,300

 

 

 

41,800

 

 

 

41,800

 

Adjustment for diluted shares

 

 

8,000

 

 

 

8,000

 

 

 

8,000

 

 

 

8,000

 

Weighted-average common shares outstanding - diluted

 

 

49,300

 

 

 

49,300

 

 

 

49,800

 

 

 

49,800

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income per share - diluted

 

$

0.42

 

 

$

0.50

 

 

$

0.48

 

 

$

0.80

 

Non-GAAP net income per share - diluted

 

$

0.84

 

 

$

0.92

 

 

$

1.29

 

 

$

1.59